Mr. Balagopal Chandrasekhar, has a professional experience of more than 42 years, when he has been at the helm of businesses. He served the Indian Administrative Service (IAS) for more than 6 years. Then he started a bio-medical devices company which grew to world class levels and was eventually merged with the world leader in the business. He joined the Board of Directors of Federal Bank as an Independent Director, and then served as the Chairman of the Board. He has been associated with 64 CODON from its early stage.

Bala San, as he is fondly called, supports the Kerala entrepreneurship ecosystem, and is mentor/advisor to a few startups. He is closely associated with Kerala Startup Mission (KSUM), Centre for Management Development, TIMed – the Medical Devices Incubator of SCTIMST, IIT Palakkad, etc. He is a sought after speaker to professional bodies and students, participates in webinars and discussions online, and is active on social media. He and his wife Vinita, manage ANAHA Trust, which funds socially useful programs and projects, in the fields of primary health, primary education, and rural livelihoods.

He has written books:
• On a clear day you can see India & The view from Kollam – Two books that describe the professional life of an officer in the Indian Administrative Service (IAS).
• Maveli & Market Intervention – is a book about how the public distribution service organization of Kerala – Supplyco, implemented innovative practices for people’s welfare.
• Below The Radar – is a book which dives deep and uncovers the many modern manufacturing companies in Kerala and tells how they grew by stealth mode.

Meet Abhilash Subhash, a seasoned Serial Entrepreneur and Angel Investor with an impressive 18-year journey in the IT industry. As a CEO, his expertise lies in DevOps, Application Development, Cloud Consulting, and IT infrastructure services. Abhilash's illustrious career spans various management roles, including CEO, CTO, and IT Director for companies across India, the US, and Europe.

With a technical background, he remains at the forefront of innovation, continuously exploring new technologies to integrate into our business services. His customer-oriented approach ensures a seamless collaboration with clients and our dedicated team, delivering best-in-class solutions that outshine the competition.

With a passion for startups, Abhilash actively engages in mentoring and angel investing, providing invaluable guidance to early-stage ventures. His investments have been remarkably successful, making him an influential figure in the startup ecosystem.
Abhilash's core strengths revolve around Business Strategy Formation, Innovative Development, Relationship Development, Organizational Development, and General Management. He excels at creating long-term visions for companies and crafting strategies to turn dreams into reality.

What sets Abhilash apart is his hands-on approach and strong commitment to customer satisfaction. As a customer-centric leader, he collaborates closely with clients and team members to deliver exceptional solutions that stand out in the market.

Throughout his diverse career, Abhilash has earned a reputation for delivering high-quality results while maintaining a friendly and approachable demeanour. His exceptional communication skills enable him to build strong relationships with stakeholders at all levels. From Business Development to Leadership, Abhilash's expertise encompasses a broad spectrum of skills, making him a valuable asset in any team or organization.

Dr. Hari has been working as a consultant to the healthcare industry globally for more than 20 years across all commercial functions. In his consulting projects, he develops forecast models, valuation models, business cases and commercial strategy for several pharmaceutical and biotechnology products. He is also an expert in health economics and market access and develops cost effectiveness models and budget impact models for companies launching new medicines and medical devices. Dr. Hari’s work enables companies achieve optimal pricing and market access for new medicines and interventions. This type of work includes collation of real world evidence from patient registries, systematic literature reviews and meta analyses to support the market access strategy developed.

He has founded and run a start-up in the healthcare space in the US. In this venture, he licensed in a patent from the University of Florida and raised funding from angel investors to commercialize oncology and sports focused products.

He has worked in major pharmaceutical companies in the US and Switzerland early on in his career (Bayer – USA, Novartis – Basel).

He also works part-time as a hospital doctor in the UK NHS in General Internal Medicine.

Dr. Hari has an MBBS degree (Medicine) from Trivandrum Medical College, India, an MSc in International Health Policy (Health Economics stream) from London School of Economics, an MSc in Leadership and Strategy (Sloan Program) from London Business School, an MSc in Finance (MiF) from London Business School, an MBA (MIM) from Thunderbird Business School (Arizona State University, USA) and an MBA from Cardiff Business School.

Dr. Hari is also an avid runner who has participated in several marathons.

LinkedIn: https://www.linkedin.com/in/harit3/

Dr. Shaji K Ayillath is the visionary founder and director of 64 Codon. While pursuing a membership program at the Royal College of Edinburgh, UK, in 2009, he had the opportunity to work with one of the world's best biorepositories at Edinburgh Cancer Hospital. This experience sparked a profound thought in his mind - "In India, why are we throwing away precious human biological samples as mere biomedical waste?" Driven by this question, he decided to return to India and embark on a journey to transform biobanking in the country.

In 2016, he founded 64 Codon and began building a dedicated team around his vision. With unwavering determination, Dr. Shaji navigated important regulatory aspects and steered the company towards its mission. The team shared his passion for developing the biobank business to benefit the Indian population's future healthcare. In 2020, 64 Codon achieved a remarkable milestone by launching the first commercial open network biobank in India.

Dr. Durga Prasan, a co-founder and highly experienced medical oncologist, has accumulated close to two decades of consulting experience. Throughout his clinical and academic practice, he has been captivated by the "Why" question, which inspired his journey to become a Clinician Scientist. Dr. Prasan's passion for research and desire to tackle complex problems led him to seek out a team that shared his goals. His quest brought him to 64 Codon, where he now leads their Innovation projects.

Dr. Prasan's impressive academic qualifications and pursuit of a Ph.D. in life sciences at Mazumdar Shaw Medical Foundation, Bangalore, alongside his contributions to research collaborations with partnering institutions, demonstrate his dedication to advancing medical knowledge and practice.



Sreejith brings over 22 years of IT experience, having worked with top multinational companies across diverse industries, including Life Science, Oil & Gas, Financial Services, Telecom, E-commerce, Products, Healthcare, and Public Services. As a Data Scientist, he plays a pivotal role in 64 Codon's artificial intelligence project for Cancer research.

His expertise in Data Science, Technology Architecture, Development, Support, Testing, QA, Administration, and Project Management ensures that our organization is at the forefront of cutting-edge research and technology.

Dr. Dinsha K. N is a dental professional and researcher with a Master’s degree in Oral Pathology and Microbiology from Rajiv Gandhi University of Health Sciences (RGUHS), Bangalore.

With prior experience as a dental faculty member, Dr. Dinsha has developed a strong foundation in academics, pathology, and scientific research. She has contributed to research in her field through published research work and authorship of a book based on her area of research.

Her primary areas of research interest include molecular biology and cancer research, with a particular interest in understanding disease mechanisms at the molecular level and exploring research approaches that can contribute to advances in cancer biology.

Currently serving as a Research Coordinator at 64 Codon, Dr. Dinsha is involved in coordinating research initiatives and fostering collaborations within the bioscience and healthcare research ecosystem.